What is a Mobitz type I block?
Mobitz type I, also called Wenckebach block, is a form of second-degree AV block. The characteristic electrocardiographic pattern is progressive PR interval prolongation followed by a nonconducted P wave, after which the cycle resets. This delay typically originates within the atrioventricular (AV) node. While often a benign and transient finding in athletes or young individuals, it may indicate degenerative disease in older populations. Understanding the various heart block types is essential for clinical triage. Mobitz type I is usually AV nodal and has a better prognosis than Mobitz type II, which is typically infranodal and more likely to progress.
What causes Mobitz type I blocks?
Mobitz type I usually results from progressive delay in AV nodal conduction until one atrial impulse fails to conduct. Heightened vagal tone or exposure to AV nodal blocking agents, such as beta-blockers or calcium channel blockers, can slow AV nodal conduction. Other causes include myocarditis, digoxin toxicity, acute inferior myocardial infarction, and recent cardiac surgery. The usual AV nodal location helps distinguish Mobitz type 1 vs type 2, as Mobitz type II is typically caused by disease below the AV node in the His-Purkinje system.
What are the signs and symptoms of Mobitz type I blocks?
Most individuals with Mobitz type 1 are asymptomatic. However, a significant slowing of the ventricular rate may lead to fatigue, lightheadedness, or near-syncope, particularly during physical activity. In inferior myocardial infarction, AV nodal ischemia or increased vagal tone can trigger 2nd degree heart block type 1. In a 2-to-1 heart block, every other P wave is nonconducted, so the rhythm may be difficult to classify as Mobitz type I or Mobitz type II on surface ECG alone.
How is a Mobitz type I block diagnosed?
Diagnosis centers on identifying the characteristic PR interval behavior through 12-lead ECG or continuous telemetry monitoring. Distinguishing Mobitz 1 vs Mobitz 2 patterns is the main goal of electrocardiographic assessment. For selected symptomatic individuals, exercise stress testing can help determine whether AV conduction improves with sympathetic tone, which supports an AV nodal level of block.
How is a Mobitz type I block treated?
Management primarily focuses on identifying and addressing reversible contributors, such as electrolyte imbalances or ischemia. Asymptomatic Mobitz type I usually requires no treatment beyond observation and correction of reversible causes. Symptomatic bradycardia from Mobitz type I often responds to atropine. If medications are contributing, reducing or discontinuing AV nodal blockers can resolve the block. Temporary pacing is reserved for hemodynamic instability or failure to respond. Permanent pacing is rarely needed for Mobitz type I, but may be considered if symptoms persist despite correction of reversible causes or if higher-risk conduction disease is suspected.
What are the most important facts to know about Mobitz type I blocks?
- Mobitz type I (Wenckebach block) involves progressive PR interval prolongation followed by a nonconducted P wave, often benign in athletes and during vagal states.
- Because Mobitz type I is usually AV nodal, it generally has a better prognosis than Mobitz type II, which is typically infranodal.
- Most patients are asymptomatic, but bradycardia can cause fatigue, lightheadedness, dizziness, or near-syncope, especially when Mobitz type I block presents in acute settings such as inferior myocardial infarction.
- Diagnosis is based on ECG findings: progressive PR interval prolongation followed by a nonconducted P wave.
- Treatment focuses on correcting reversible causes. Atropine may be used for symptomatic bradycardia, and pacing is reserved for unstable or persistent cases.
References
- Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A. J. S., Deharo, J. C., Delgado, V., Diller, G. P., Israel, C. W., Keren, A., Knops, R. E., Kotecha, D., . . . Tolosana, J. M. (2021). 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) with the special contribution of the European Heart Rhythm Association (EHRA). European Heart Journal, 42(35), 3427–3520. https://doi.org/10.1093/eurheartj/ehab364
- Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., Lee, R., Marine, J. E., McLeod, C. J., Oken, K. R., Patton, K. K., Pellegrini, C. N., Selzman, K. A., Thompson, A., & Varosy, P. D. (2019). 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation, 140(8). https://doi.org/10.1161/CIR.0000000000000628
- Mangi, M. A., Jones, W. M., Mansour, M. K., & Mohanty, S. (2023, August 14). Second-degree atrioventricular block. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482359/
- Mitchell, L. B. (2024, September). Atrioventricular block (AV block). Merck Manual Professional Edition. https://www.merckmanuals.com/professional/cardiovascular-disorders/specific-cardiac-arrhythmias/atrioventricular-block
- Sauer, W. H. (2024, October 1). Second-degree atrioventricular block: Mobitz type I (Wenckebach block). UpToDate.